At FCI, we provide comprehensive and cutting-edge cancer treatment and care for our patients. We are best known for our multi-disciplinary approach to treating and managing all types of cancers. The institute is located within various Fortis Hospitals across the country and has a team of highly experienced and skilled oncologists, surgeons, and support staff who provide personalised and compassionate care to cancer patients. The first FCI was established in 2014 at Fortis Hospital, Mohali.

As a forward-thinking Centre of Excellence, FCI delivers precision oncology treatments, offers genomic medicine, and features a dedicated daycare centre, alongside fully equipped medical, surgical, and radiation oncology departments. the institute endeavors to provide state-of-the-art treatments and therapies like CAR T-Cell, which helps treat relapsed or refractory B-Cell Cancers like lymphomas, when other standard treatments have been unsuccessful.

With the addition of Gamma Knife Esprit (the first in South Asia) a state-of-the-art, non-invasive neurosurgical technology that has redefined the landscape of brain treatment, our team at FCI is able to provide single session, precision treatment (ensuring sub-millimeter accuracy, targeting specific areas) for brain tumors. Gamma Knife is a proven technology and is considered the gold standard for brain radiosurgery as the system utilises a multitude of highly focused gamma-ray beams to converge at a specific point within the brain. This convergence is exceptionally precise, allowing for the treatment of intricate brain conditions without affecting the surrounding healthy tissue. With Gammma Knife treatments, our patients can experience unmatched tumor control, safe an accurate treatment and improved quality of like.    

In line with the aim of providing the best technology to treat and defeat cancers, FCI is now equipped with MR Linac - a groundbreaking system that seamlessly integrates a 1.5T MR, ensuring an uncompromised design for unparalleled accuracy in visualising the tumor and organs at risk. The transformative capabilities of MR Linac has the potential to revolutionise personalised cancer treatment through MRI guided radiation therapy (MRgRT). The integration of a high-field MR allows for real-time visualization of tumor during radiation delivery, ensuring that treatment adjustments can be made instantly, based on the most up-to-date information.

To ensure that patients get the most effective and accurate treatment, FCI team hosts regular Molecular Tumor Board, bringing together a panel of experts (from across the Fortis Network) who review cancer patients’ genetic and molecular data along with other diagnostic tests to recommend personalised treatment options which ultimately enhances the outcomes.

In addition, FCI also provides comprehensive cancer screenings, options for regular or robotic surgeries, psycho-social counselling for cancer patients and care givers, access to support groups and end-of-life care to those who need it.

In addition, FCI also provides comprehensive cancer screenings, options for regular or robotic surgeries, psycho-social counselling for cancer patients and care givers, access to support groups and end-of-life care to those who need it.

In addition, FCI also provides comprehensive cancer screenings, options for regular or robotic surgeries, psycho-social counselling for cancer patients and care givers, access to support groups and end-of-life care to those who need it.

In addition, FCI also provides comprehensive cancer screenings, options for regular or robotic surgeries, psycho-social counselling for cancer patients and care givers, access to support groups and end-of-life care to those who need it.

In addition, FCI also provides comprehensive cancer screenings, options for regular or robotic surgeries, psycho-social counselling for cancer patients and care givers, access to support groups and end-of-life care to those who need it.